GC

Glenn Cross

Mr Cross has 40 years' experience in life science sector domestically and internationally, including over 20 years in senior executive capacity. He was formerly CEO and COO of AusBiotech 13 years. He is member of Risk and Human Resource Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/2575,076N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
06/12/24
Issued
5,000$2.670$13,350Conversion of securities
06/12/24
Exercise
5,000$2.670$13,350Conversion of securities
21/08/24
Issued
15,000$0.080$1,200Issued under employee share plan
11/10/23
Buy
40,000$0.650$26,000On-market trade
11/10/23
Buy
26,000$0.650$16,900On-market trade